Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC

NCT00254904 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

839

Enrollment

INDUSTRY

Sponsor class

Stopped See Termination Reason in Detailed Description

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: PF-3512676
DRUG: Cisplatin
DRUG: Gemcitabine + Cisplatin

Sponsor

Pfizer